Form 4: Virios Therapeutics CEO Gregory Scott Duncan Acquires Stock Options
SEC Form 4 Filing
Gregory Scott Duncan, CEO of Virios Therapeutics, acquired 138,835 stock options on February 26, 2024, as reported in a Form 4 filing with the SEC.
Summary
- Gregory Scott Duncan, the CEO of Virios Therapeutics, filed a Form 4 with the SEC.
- The filing reports a transaction that occurred on February 26, 2024.
- Duncan acquired 138,835 stock options with an exercise price of $0.357.
- The stock options vest 100% on February 26, 2025, and expire on February 26, 2034.
- Following the transaction, Duncan directly owns 138,835 derivative securities (stock options).
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating the CEO's acquisition of stock options, which is neither particularly positive nor negative on its own. The alignment of interests is a slight positive.
Positives
- The acquisition of stock options by the CEO could align his interests with those of the shareholders, incentivizing him to improve the company's performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the CEO's acquisition of stock options, which is a common form of executive compensation.
Stakeholder Impact
- The acquisition of stock options by the CEO could potentially align his interests more closely with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/26/2024 | Date of the stock option transaction. |
| 02/26/2025 | Date the stock options vest 100%. |
| 02/26/2034 | Expiration date of the stock options. |
| 02/28/2024 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Virios Therapeutics, Stock Options, Gregory Scott Duncan, VIRI, SEC Filing, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.